Scleromyxedema revisited
- 1 January 2003
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 42 (1) , 31-35
- https://doi.org/10.1046/j.1365-4362.2003.01565.x
Abstract
Scleromyxedema is a rare disease characterized by papular mucinous deposits, dermal fibroblast proliferation, and a monoclonal paraproteinemia. Its chronic course tends to be complicated by gastrointestinal, muscular, pulmonary, and neurologic disorders. We review the literature to identify the common systemic manifestations and suggest a clinical approach to this disorder. This should include: identification of the characteristic lesions, a skin biopsy, and serum protein electrophoresis. A thyroid evaluation may help differentiate this condition from others. An early neurologic, gastrointestinal, and cardiovascular evaluation should be considered.Keywords
This publication has 31 references indexed in Scilit:
- Scleromyxedema: Response to high-dose intravenous immunoglobulin (hdIVIg)Journal of the American Academy of Dermatology, 2000
- ScleromyxedemaJournal of the American Academy of Dermatology, 1995
- Stimulation of fibroblasts by paraprotein in scleromyxedemaJournal of the American Academy of Dermatology, 1989
- Scleromyxedema myopathy: case report and review of the literatureArthritis & Rheumatism, 1988
- ScleromyxedemaMedicine, 1988
- Interne Krankheitsbefunde bei Skleromyxödem Arndt-GottronDeutsche Medizinische Wochenschrift (1946), 1986
- The acquired cutaneous mucinosesArchives of internal medicine (1960), 1984
- Major Surgery and ScleromyxedemaNew England Journal of Medicine, 1984
- Skleromyxödem Arndt-Gottron und assoziierte PhänomeneDermatology, 1984
- Papular mucinosis. A clinicopathologic study of four patientsArchives of Dermatology, 1982